226
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Cellular uptake on N- and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells

&
Pages 801-808 | Received 19 Mar 2013, Accepted 25 Jun 2013, Published online: 13 Aug 2013

References

  • Bais MV, Kumar S, Tiwari AK, et al. Novel Rath peptide for intracellular delivery of protein and nucleic acids. Biochem Biophys Res Commun 2008;370:27–32
  • Mundt E, Beyer J, Müller H. Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol 1995;76:437–43
  • Lombardo E, Maraver A, Espinosa I, et al. VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis. Virology 2000;277:345–57
  • Mundt E, Köllner B, Kretzschmar D. VP5 of infectious bursal disease virus is not essential for viral replication in cell culture. J Virol 1997;71:5647–51
  • Wu Y, Hong L, Ye J, et al. The VP5 protein of infectious bursal disease virus promotes virion release from infected cells and is not involved in cell death. Arch Virol 2009;154:1873–82
  • Hosack DA, Dennis Jr G, Sherman BT, et al. 2003. Identifying biological themes within lists of genes with EASE. Genome Biol 2012;4:R70
  • Weller K, Lauber S, Lerch M, et al. 2005. Biophysical and biological studies of end-group-modified derivatives of Pep-1. Biochemistry 2012;44:15799–811
  • Yao K, Goodwin MA, Vakharia VN. Generation of a mutant infectious bursal disease virus that does not cause bursal lesions. J Virol 1998;72:2647–54
  • Li Z, Wang Y, Xue Y, et al. Critical role for voltage-dependent anion channel 2 in infectious bursal disease virus-induced apoptosis in host cells via interaction of VP5. J Virol 2012;86:1328–38
  • Ma O, Cai WW, Zender L, et al. MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. Cancer Res 2009;69:2559–67
  • Neubauer NL, Ward EC, Patel P, et al. Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis. Horm Cancer 2011;2:170–81
  • Pradhan M, Baumgarten SC, Bembinster LA, Frasor J. CBP mediates NF-κB-dependent histone acetylation and estrogen receptor recruitment to an estrogen response element in the BIRC3 promoter. Mol Cell Biol 2012;32:569–75
  • Wang Y, Tang X, Yu B, et al. Gene network revealed involvements of Birc2, Birc3 and Tnfrsf1a in anti-apoptosis of injured peripheral nerves. PLoS One 2012;7:e43436 (1–10)
  • Epis MR, Giles KM, Kalinowski FC, et al. Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells. J Biol Chem 2012;287:35251–9
  • Park MH, Nishimura K, Zanelli CF, Valentini SR. Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids 2010;38:491–500
  • Ho AL, Musi E, Ambrosini G, et al. Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. PLoS One 2012;7:e40439 (1–16)
  • Khalili JS, Yu X, Wang J, et al. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res 2012;18:4345–55
  • Caballero OL, Zhao Q, Rimoldi D, et al. Frequent MAGE mutations in human melanoma. PLoS One 2010;5:1–7
  • Guillaume B, Stroobant V, Bousquet-Dubouch MP, et al. Analysis of the processing of seven human tumor antigens by intermediate proteasomes. J Immunol 2012;189:3538–47
  • Båvner A, Matthews J, Sanyal S, et al. EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation. Nucleic Acid Res 2005;33:3561–9
  • Lin ZY, Chuang WL. Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells. Biomed Pharmacother 2012;66:454–8
  • Lin CW, Kuo JH, Jan MS. The global gene-expression profiles of U-937 human macrophages treated with Tat peptide and Tat-FITC conjugate and Tat-FITC conjugate. J Drug Target 2012;20:515–23
  • Fotin-Mleczek M, Welte S, Mader O, et al. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J Cell Sci 2005;118:3339–51
  • Fisher AA, Ye D, Sergueev DS, et al. Evaluating the specificity of antisense oligonucleotide conjugates. A DNA array analysis. J Biol Chem 2002;277:22980–4
  • Waldeck W, Pipkorn R, Korn B, et al. Transporter molecules influence the gene expression in HeLa cells. Int J Med Sci 2009;6:18–27

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.